An insight into the Mental Health Space and 3H’s experience in Paediatrics Major Depression Disorder Study in Japan
Mental health is a crucial component of overall well-being. It affects how one thinks, feels, and interact wit […]
3H’s emotional case study of breast cancer patient: Enrolling for Clinical Trial.
Breast cancer is a common female cancer occurring globally, and it is the most common cancer among Japanese wo […]
3H’s DCT approach for Convenience, Diversity, and Data-Driven Insights.
The Way Forward for Decentralise Clinical Trials in Japan: As Decentralized clinical trials, brings participan […]
Uchiken: 3H’ Clinical Trial Specialized Nursing Station
Uchiken; 3H`s owned Home Nursing station achieves accreditation as Certified Home Nursing Service Provider, En […]
3H Medi Solution and Genequest are collaborating to establish a patient registry for inflammatory bowel disease (IBD)
Initiating the provision of analysis information on differences in drug effects for each genetic polymorphism […]
The Successful attaining the Recruitment Targets in Japan and 3H’s optimizing holistic approach for Challenging Clinical Trials.
When conducting clinical trials, it is important to have a well-constructed recruitment pathway. Clinical tria […]
3H’s evolved Patient Recruitment approach for Decentralized Clinical Trials
Recruitment remains a key challenge in clinical trial conduct. With the clinical trial protocols becoming more […]
3H is participating at DIA-2022 @Booth# 1004
A paradigm shift of Digital Health Technologies and 3H’s roles for transforming the Clinical Trial conduct in Japan.
The world is transitioning into the information age in healthcare and modern digital health technologies have […]
Initiation of Providing “Fukusapo”, an Adverse Drug Reaction Management Supporting Tool for Patients Receiving Treatment with Immune Checkpoint Inhibitors
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; Representative Director, President, Gyo Sagara; “ONO”) and 3H Clin […]
